During the past decade, Praxis für Interdisziplinäre Onkologie und Hämatologie GbR conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis für Interdisziplinäre Onkologie und Hämatologie GbR" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Praxis für Interdisziplinäre Onkologie und Hämatologie GbR" are "Breast Cancer" (7 trials), "Colorectal Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "Praxis für Interdisziplinäre Onkologie und Hämatologie GbR" in a lesser frequency.

Most popular intervention types in "Praxis für Interdisziplinäre Onkologie und Hämatologie GbR" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Trastuzumab" (5 trials), "Paclitaxel" (4 trials), "Pertuzumab" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Praxis für Interdisziplinäre Onkologie und Hämatologie GbR" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Praxis für Interdisziplinäre Onkologie und Hämatologie GbR". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Praxis für Interdisziplinäre Onkologie und Hämatologie GbR, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis für Interdisziplinäre Onkologie und Hämatologie GbR, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".